Daffodil Health vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 35)
Daffodil Health logo

Daffodil Health

EmergingDigital Health

Health Plan Administration AI

Raised $16.3M Series A (Feb 2026). AI platform automating health plan administration and claims processing for regional and self-funded employer health plans.

AI VisibilityBeta
Overall Score
D35
Category Rank
#562 of 596
AI Consensus
76%
Trend
stable
Per Platform
ChatGPT
38
Perplexity
29
Gemini
32

About

Daffodil Health is an AI platform that automates health plan administration and claims processing workflows for regional health plans and self-funded employer groups — a segment of the health insurance market that processes billions in claims annually through predominantly manual review workflows. The company raised $16.3 million in Series A financing in February 2026, targeting the operational efficiency gap between large national payers (who have invested heavily in automation) and regional and employer-sponsored plans that still rely on manual claims adjudication.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

35
Overall Score
90
#562
Category Rank
#2
76
AI Consensus
83
stable
Trend
stable
38
ChatGPT
92
29
Perplexity
93
32
Gemini
89
38
Claude
96
33
Grok
95

Key Details

Category
Health Plan Administration AI
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Daffodil Health
Health Plan Administration AI

Integrations

Only Moderna
Moderna is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.